• search
Country
CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Formulation Studies

Formulation Studies

We offer one stop solution from early phase development to commercial manufacturing.

At Aurigene, we have a highly skilled scientific team with expertise in variety of dosage forms like OSDs, injectable and topicals. At our state-of-the-art facility, we handle complex oral solid dosage forms, oral liquids and parenteral dosage forms like aqueous liquid injectables, non-aqueous liquid injectables, lyophilized injectables and ophthalmic solutions. We specialize in pediatric dosage forms, fixed dose combinations and modified-release dosage forms. We also support for development of customized formulations for animals. Our expert team is having extensive experience in developing complex formulations and provide tailored solutions to your problems and help to optimize the development time and cost.

Our team is committed to delivering quality results in a time-bound and cost-effective manner at each stage of the development process. We also evaluate container closure systems, storage and transportation conditions.

ICH-compliant stability studies along with a range of conditions to cover various climatic zones across the globe, help in making decisions early in the drug development cycle.

With decades of experience in formulation development, our scientists look forward to accelerating the time to market of your molecule.

Speak to our experts

Solid Orals

  • Immediate-release tablets (chewable tablets, orally disintegrating tablets, sublingual tablets and bi-layer tablets)
  • Modified release tablets (monolayer, bilayer and mini tablets)
  • Fixed dose combinations (monolayer, Bilayer and Multi particulate systems (granules, pellets or mini-tablets and combinations there off in capsule)
  • Hard Capsules (hard gelatin or HPMC capsules with powder in capsule, pellets in capsules and soft gelatin capsules)
  • Multiparticulate systems (pellets and mini tablets)
  • Powder in sachet for solution or suspension

Oral Liquids

  • Oral solutions with dosing cup
  • Oral drops with dosing device
  • Oral suspension
  • Oral emulsions

Parenterals

  • Aqueous liquid injectables
  • Non-aqueous liquid injectables
  • Lyophilized injectables
  • Ophthalmic and otic solutions
  • Nasal solutions (drops to be instilled into nostrils)

Topical

  • Ointment
  • Cream
  • Gel

Why Aurigene Pharmaceutical Services?

Services across the product lifecycle

US FDA inspected lab and manufacturing facilities

Experience with advanced formulation technologies

20+ years of experience in formulation

Virtual Tour

 

Contact Us

Country
CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
resourceMainImage

JUNE 28, 2022

Neoantigen Specific T cells For Cancer Immunotherapy

Neoantigen specific T cells for cellular cancer immunotherapy An effective anti-tumor immune response in human is marked by presence of T cells reactive against neoantigens. Neoantigens are HLA-bound unique peptides arise from tumor-specific somatic mutations. Neoantigens are highly immunogenic because they are not present in normal tissues and hence...

Read More
resourceMainImage

Building successful long-term partnerships with CDMOs from early drug discovery through commercialization

Building successful long-term partnerships with CDMOs from early drug discovery through commercialization Maximizing efficiency in drug research, development, and manufacturing is crucial for turning new innovations into therapeutic and financial benefits. Over the past couple of decades, pharmaceutical companies have increasingly turned to contr...

Read More
resourceMainImage

Technology meets sustainability - How a complex API development process goes green

We are always looking for ways to enhance the sustainability of our products and services. Our team successfully developed a scalable manufacturing process for the API product of one of our Biotech clients using eco-friendly manufacturing technologies. Read the case study to learn more. ...

Read More

Alternate end-game strategies towards Nirmatrelvir synthesis: Defining a continuous flow process for the preparation of an anti-COVID drug

2023

Scalable alternate end-game strategies for the synthesis of the anti-COVID drug molecule Nirmatrelvir (1,PF-07321332) have been described. The first involves a direct synthesis of 1 via amidation of the carboxylic acid 7 (suitably activated as a mixed anhydride with either pivaloyl chloride or T3P) with the ...

Read More
View All

Frequently asked questions

What is formulation research and development?

Formulation development is a part of the drug product development process where the drug substance is combined with suitable excipients and processed to produce stable drug products such as tablets, capsules, injectables, topical cream/gel.

What is the role of formulations in pharmaceutics?

The formulation in pharmaceuticals is a process where the drug substance/API is mixed with an excipient to form a final drug product by considering the particle size, pH, stability, polymorphism, and solubility. It helps to decide the most optimal delivery mode such as oral, parenteral, pulmonary, nasal, topical, ophthalmic or rectal.

What does drug formulation mean?

Drug formulation is the process where a drug substance/ Active Pharmaceutical Ingredient (API) is converted into a final human consumable oral, parenteral, pulmonary, nasal, topical, ophthalmic, or rectal formulation to treat diseases.

×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack